Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( (HK:6821) ) is now available.
Asymchem Laboratories (Tianjin) Co., Ltd., a Hong Kong-listed pharma and biotech services provider, offers contract research and manufacturing support to global drug developers. The company operates through H shares in Hong Kong, giving offshore and mainland investors structured access to China’s life sciences outsourcing industry.
The company updated its final dividend announcement for the year ended 31 December 2025, confirming a payout of RMB 13 per 10 shares subject to shareholder approval on 10 June 2026. It detailed Hong Kong share register arrangements, key dates for ex-dividend, book closure and payment, and clarified that non-resident enterprise and individual investors will generally face a 10% withholding tax on dividends, providing clearer visibility on post-tax returns for different shareholder groups.
The most recent analyst rating on (HK:6821) stock is a Hold with a HK$120.00 price target. To see the full list of analyst forecasts on Asymchem Laboratories (Tianjin) Co., Ltd. Class H stock, see the HK:6821 Stock Forecast page.
More about Asymchem Laboratories (Tianjin) Co., Ltd. Class H
Asymchem Laboratories (Tianjin) Co., Ltd. is a Hong Kong-listed pharmaceutical and biotechnology services company focused on laboratory and manufacturing solutions for drug development. Through its H share listing, it serves both mainland China and international investors seeking exposure to the life sciences outsourcing sector.
Average Trading Volume: 558,380
Technical Sentiment Signal: Buy
Current Market Cap: HK$49.49B
For a thorough assessment of 6821 stock, go to TipRanks’ Stock Analysis page.